Dosing for cannabis products may prove to be one of several tough questions that the US Food and Drug Administration must answer in trying to implement some regulatory control over the industry.
The FDA already has clinical evidence for the dose of GW Pharmaceuticals PLC's Epidiolex (cannabidiol), which was approved in...








